12/4
01:01 pm
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
12/2
10:16 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
12/2
10:16 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
11/17
12:23 pm
acad
Rating for ACAD
Low
Report
Rating for ACAD
11/6
10:34 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
11/6
10:34 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
11/6
05:05 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
11/6
05:05 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
10/21
08:03 am
acad
ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $33.00 price target on the stock.
Low
Report
ACADIA Pharmaceuticals (NASDAQ:ACAD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $33.00 price target on the stock.
10/21
06:48 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
10/21
06:48 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
10/21
06:11 am
acad
Acadia Pharmaceuticals initiated with a Buy at Citi
Medium
Report
Acadia Pharmaceuticals initiated with a Buy at Citi
9/29
08:06 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
9/24
10:51 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
9/24
10:51 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
9/9
10:46 am
acad
Rating for ACAD
Low
Report
Rating for ACAD